Wexler Wallace Involved with Xarelto Dangerous Drug Litigation Bellwethers in St. Louis
Wexler Wallace is currently leading the discovery and trial efforts in five out of seven cases selected for bellwether trials in the Xarelto Dangerous Drug Litigation pending in St. Louis state court. These cases center on damages Plaintiffs have suffered from taking Xarelto, an anticoagulant used for a variety of blood-thinning medical purposes. The Plaintiffs have filed suits alleging that they or their family members suffered severe bleeding due to Xarelto’s defective design and inadequate warning label, among other things.
The cases are part of a larger group of Xarelto cases pending in St. Louis in the Twenty-Second Judicial Circuit Court in the City of St. Louis (Case No. 1522-CC10520-01). Judge Michael K. Mullen is the Presiding Judge, and the first case will be scheduled for trial in early 2018.
As part of the bellwether process, attorney Tim Jackson and other members of the firm are taking depositions of Plaintiffs, doctors, and other witnesses in these cases. This will be followed by the depositions of experts, and finally, the plaintiffs will choose the first case to be tried.
The cases are consolidated under the heading Turley et al. v. Janssen Research & Development, LLC, et al. For more information about the Xarelto Dangerous Drug Litigation, please contact Wexler Wallace.